Summary
Stryker Corporation announced a significant change to its business segment reporting structure, effective December 31, 2021. The company is consolidating its operations into two distinct reportable segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. This realignment is driven by a shift in internal reporting and management structure, including changes in executive responsibilities with Group Presidents J. Andrew Pierce and Spencer S. Stiles overseeing the respective new segments. This change is intended to better reflect how Stryker manages its diverse business operations and will impact how historical product sales information is presented. The company has provided recast historical product sales data in Exhibit 99.1 to allow investors to analyze performance under the new segment structure. While this information is for informational purposes and not formally filed, it offers crucial context for understanding Stryker's future financial reporting and operational focus.
Key Highlights
- 1Stryker is reorganizing its business segments into two new reportable segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.
- 2This change is effective as of December 31, 2021.
- 3The realignment aligns with the company's new internal reporting structure and management approach.
- 4The transition involves a division of responsibilities among Group Presidents J. Andrew Pierce (MedSurg and Neurotechnology) and Spencer S. Stiles (Orthopaedics and Spine).
- 5Recast historical product sales information reflecting the new segment structure is provided in Exhibit 99.1.
- 6This move aims to enhance clarity on how Stryker manages its business units and reports financial performance.